These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22166919)

  • 1. Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.
    Passero LF; Carvalho AK; Bordon ML; Bonfim-Melo A; Toyama MH; Corbett CE; Laurenti MD
    Inflamm Res; 2012 Mar; 61(3):255-63. PubMed ID: 22166919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation.
    Passero LF; Carvalho AK; Bordon ML; Bonfim-Melo A; Carvalho K; Kallás EG; Santos BB; Toyama MH; Paes-Leme A; Corbett CE; Laurenti MD
    Parasit Vectors; 2012 Mar; 5():64. PubMed ID: 22463817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of Leishmania (Viannia) shawi infection in BALB/c mice after immunization with soluble antigen from amastigote forms.
    Passero LF; Da Costa Bordon ML; De Carvalho AK; Martins LM; Corbett CE; Laurenti MD
    APMIS; 2010 Dec; 118(12):973-81. PubMed ID: 21091779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes.
    Passero LF; Marques C; Vale-Gato I; Corbett CE; Laurenti MD; Santos-Gomes G
    Arch Dermatol Res; 2012 Jan; 304(1):47-55. PubMed ID: 21882046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Leishmanization Using
    Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F
    Front Immunol; 2020; 11():1725. PubMed ID: 33193290
    [No Abstract]   [Full Text] [Related]  

  • 6. Total Leishmania antigens with Poly(I:C) induce Th1 protective response.
    Sanchez MV; Eliçabe RJ; Di Genaro MS; Germanó MJ; Gea S; García Bustos MF; Salomón MC; Scodeller EA; Cargnelutti DE
    Parasite Immunol; 2017 Nov; 39(11):. PubMed ID: 28901553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology, humoral and cellular immune response in the murine model of Leishmania (Viannia) shawi.
    Passero LF; Marques C; Vale-Gato I; Corbett CE; Laurenti MD; Santos-Gomes G
    Parasitol Int; 2010 Jun; 59(2):159-65. PubMed ID: 20060062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi.
    Passero LF; Sacomori JV; Tomokane TY; Corbett CE; da Silveira FT; Laurenti MD
    Parasitol Res; 2009 Nov; 105(6):1741-7. PubMed ID: 19756748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice.
    Salari S; Sharifi I; Keyhani AR; Ghasemi Nejad Almani P
    Parasit Vectors; 2020 Aug; 13(1):415. PubMed ID: 32787908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice.
    Afonso-Cardoso SR; Rodrigues FH; Gomes MA; Silva AG; Rocha A; Guimaraes AH; Candeloro I; Favoreto S; Ferreira MS; de Souza MA
    Korean J Parasitol; 2007 Dec; 45(4):255-66. PubMed ID: 18165707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
    Cargnelutti DE; Salomón MC; Celedon V; García Bustos MF; Morea G; Cuello-Carrión FD; Scodeller EA
    J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
    Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
    Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of Leishmania spp. causing cutaneous leishmaniasis in the lower Amazon region, western Pará state, Brazil, reveals a putative hybrid parasite, Leishmania (Viannia) guyanensis × Leishmania (Viannia) shawi shawi.
    Jennings YL; de Souza AA; Ishikawa EA; Shaw J; Lainson R; Silveira F
    Parasite; 2014; 21():39. PubMed ID: 25083790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection.
    Yamakami K; Akao S; Sato M; Nitta Y; Miyazaki J; Tadakuma T
    Parasitol Int; 2001 Jul; 50(2):81-91. PubMed ID: 11438430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.
    Lakhal-Naouar I; Koles N; Rao M; Morrison EB; Childs JM; Alving CR; Aronson NE
    Vaccine; 2019 Jan; 37(3):516-523. PubMed ID: 30528328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
    Pinto EF; de Mello Cortezia M; Rossi-Bergmann B
    Vaccine; 2003 Sep; 21(25-26):3534-41. PubMed ID: 12922080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
    Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.